With the increased environmental awareness and the pollution potential and health hazards from many conventional pesticides, the demand for nature-based biopesticides has been rising steadily in all parts of the world.
This study examines the worldwide commercial applications of biopesticides and their markets and growth opportunities. This study also looks into the extent of market penetration of a number of biopesticides that have been recently introduced.
This study gives a clear, quantitative picture of the supply and demand scenario and highlights the technological and investment opportunities in the field.
To download the introduction chapter (for free) and to know more about this report, please visit http://www.bccresearch.com/report/CHM029C.html
Tuesday, February 23, 2010
Tuesday, February 16, 2010
Nanotechnology in Medical Applications
Reports from BCC Research that talk about the use of Nanotechnology in the Healthcare segment include:
HLC069A: Nanotechnology in Medical Applications: The Global Market
The aim of this report is to provide detailed market, technology and industry analyses to help readers quantify and qualify the market for prescription drug products incorporating nanotechnology features. Important trends are identified and sales forecasts by product categories and major country markets are provided through 2014; these are based on industry sources and considered assessment of the regulatory environment, healthcare policies, demographics, and other factors that directly affect the nanomedicine-related drug market. The wider economic environment is also taken into account.
The report examines strategies employed by companies specializing in nanomedicine to meet the challenges of this highly competitive market.
For more information on this report, please visit http://www.bccresearch.com/report/HLC069A.html
HLC058A: Global Medical Markets for Nanoscale Materials and Devices
The report addresses the global market for emerging nanotechnology applications in the medical field, including:
For more information on this report, please visit http://www.bccresearch.com/report/HLC058A.html
HLC069A: Nanotechnology in Medical Applications: The Global Market
The aim of this report is to provide detailed market, technology and industry analyses to help readers quantify and qualify the market for prescription drug products incorporating nanotechnology features. Important trends are identified and sales forecasts by product categories and major country markets are provided through 2014; these are based on industry sources and considered assessment of the regulatory environment, healthcare policies, demographics, and other factors that directly affect the nanomedicine-related drug market. The wider economic environment is also taken into account.
The report examines strategies employed by companies specializing in nanomedicine to meet the challenges of this highly competitive market.
For more information on this report, please visit http://www.bccresearch.com/report/HLC069A.html
HLC058A: Global Medical Markets for Nanoscale Materials and Devices
The report addresses the global market for emerging nanotechnology applications in the medical field, including:
- Basic medical research
- Diagnostics
- Pharmaceuticals
- Medical devices
- Medical imaging
For more information on this report, please visit http://www.bccresearch.com/report/HLC058A.html
Wednesday, February 10, 2010
21st Annual Conference on Recent Advances in Flame Retardancy of Polymeric Materials
Consumption of flame retardant chemicals is projected to reach 3.4 billion pounds worldwide by 2010, according to the latest forecast from BCC Research. With such strong growth it is imperative that professionals in the field keep up-to-date on the latest advancements and applications in flame retardancy (FR).
The 21st Annual Conference on Recent Advances in Flame Retardancy of Polymeric Materials is the premier technical event of its type in the US. Global experts in the field will discuss the latest technological findings in flame retardant materials and their important contributions to the aviation, automotive, computer, construction, electronics, and telecommunications industries. This event provides an exclusive forum for FR professionals interested in understanding the scientific technology used in the design and manufacturing of fire-resistant materials and end products.
Research scientists, chemists, design engineers, product development managers, marketing directors, business development executives, and consultants involved with the technological advancement and commercial application of flame retardant polymeric materials will benefit from attending this event.
Attendees to this meeting will:
The 21st Annual Conference on Recent Advances in Flame Retardancy of Polymeric Materials is the premier technical event of its type in the US. Global experts in the field will discuss the latest technological findings in flame retardant materials and their important contributions to the aviation, automotive, computer, construction, electronics, and telecommunications industries. This event provides an exclusive forum for FR professionals interested in understanding the scientific technology used in the design and manufacturing of fire-resistant materials and end products.
Research scientists, chemists, design engineers, product development managers, marketing directors, business development executives, and consultants involved with the technological advancement and commercial application of flame retardant polymeric materials will benefit from attending this event.
Attendees to this meeting will:
- Learn the latest technological advancements in FR.
- Discover new applications and markets for FR products
- Understand the consumer, environmental, and regulatory issues affecting the FR field
- Review new developments in standardization and testing technology
- Network with leading FR researchers and business executives
- Benefit from a wealth of knowledge accumulated throughout the 19-year history of the conference
Wednesday, February 3, 2010
Light-Emitting Diodes For Lighting Applications
The global market for light-emitting diodes (LEDs) is an estimated $5.4 billion in 2009, but is expected to increase to $8.2 billion in 2014, for a 5-year compound annual growth rate (CAGR) of 8.7%.
The second-largest segment of the market, display backlighting, is expected to reach nearly $1.6 billion in 2014, after increasing at a CAGR of 11.1% from the estimated 2009 value of $933 million.
The automotive segment is estimated to be worth nearly $267 million in 2009, and is expected to grow at a CAGR of 11.5% to reach more than $1.3 billion in 2014.
General illumination is the fastest-growing segment, with a 5-year CAGR of 16.4%. Its value is estimated at nearly $565 million in 2009 and is expected to grow to $1.2 billion in 2014.
A solid-state lighting initiative has been in place for 10 years and is targeted at replacing traditional lighting products, such as bulbs, with LEDs. BCC Research provides a comprehensive analysis of the progress to date and its overall market potential.
High-brightness light-emitting diodes operate much more efficiently than traditional light bulb products. They use a fraction of the power needed for bulb technology, have much longer operating lifetimes, and contain no substances that will harm the environment. Different material structures are used to fabricate these devices, and their fabrication methods are unique.
This study will be of interest to those in the photonics industry, manufacturers of solid-state devices, microelectronic manufacturers, those involved with automotive and transportation lighting systems, makers of mobile devices, traffic planners, municipal administrators, and those involved with general illumination in homes, offices, and industrial locations. The report also will be of interest to home designers, builders, and companies engaged in the manufacture of deposition equipment.
The second-largest segment of the market, display backlighting, is expected to reach nearly $1.6 billion in 2014, after increasing at a CAGR of 11.1% from the estimated 2009 value of $933 million.
The automotive segment is estimated to be worth nearly $267 million in 2009, and is expected to grow at a CAGR of 11.5% to reach more than $1.3 billion in 2014.
General illumination is the fastest-growing segment, with a 5-year CAGR of 16.4%. Its value is estimated at nearly $565 million in 2009 and is expected to grow to $1.2 billion in 2014.
A solid-state lighting initiative has been in place for 10 years and is targeted at replacing traditional lighting products, such as bulbs, with LEDs. BCC Research provides a comprehensive analysis of the progress to date and its overall market potential.
High-brightness light-emitting diodes operate much more efficiently than traditional light bulb products. They use a fraction of the power needed for bulb technology, have much longer operating lifetimes, and contain no substances that will harm the environment. Different material structures are used to fabricate these devices, and their fabrication methods are unique.
This study will be of interest to those in the photonics industry, manufacturers of solid-state devices, microelectronic manufacturers, those involved with automotive and transportation lighting systems, makers of mobile devices, traffic planners, municipal administrators, and those involved with general illumination in homes, offices, and industrial locations. The report also will be of interest to home designers, builders, and companies engaged in the manufacture of deposition equipment.
Friday, January 29, 2010
New Market Research reports published this week
New Market Research reports available this week from BCC Research are:
Carbon Nanotubes: Technologies and Global Markets
The primary objective of this report is threefold:
Drug-device Combinations: The Global Market
This report discusses key markets for drug device combination products. It provides descriptions of technologies and products, a review of the status of R&D initiatives and a forecast of the market through 2014. Company profiles and a patent analysis are provided as well. Example product categories that are covered include drug-eluting stents (DES), drug-eluting beads (DEB), antimicrobial catheters, antibiotic-loaded bone cements, glass ionomer cements, bone graft substitutes, antibacterial releasing dental restorative materials, biologic wound care products such as collagen-based dressings as therapeutic agents for wound healing, drug device combination products for ocular applications, photodynamic therapy, and other important niches.
For more information on this report and to download the introduction chapter for free, visit http://www.bccresearch.com/report/PHM045B.html
Antennas for Systems and Devices: Technologies and Global Markets
This report tries to make sense of the exceptionally fragmented antenna market. Prima facie, it would not be wrong to assume that the antenna market should display a level of homogeneity found in the markets of other wireless communication components such as basebands, modems, and radio frequency (RF) front ends. Such an expectation is way off the mark. What dictates the dynamics of antenna markets is the end application. It is not uncommon to notice entire antenna supply chains built closely around the interest of end-application users, rather than being heavily focused on interactions with other value adders in the telecommunications domains.
For this reason, this report considers the end-application sector as the primary classification criterion. To render the maximum level of granularity to the study, the report has identified 10 end-application categories, which are further subdivided into antenna technologies, antenna materials, and geographical regions.
On the whole, BCC Research forecasts that the future of antennas will continue to be driven by that of its end applications. However, commonalities as mentioned above will lead to the adoption of smarter technologies in antenna synthesis and operations. The market is thus likely to witness antennas that are lighter, smaller, power efficient and, most importantly, intelligent.
For more information on this report and to download the introduction chapter for free, visit http://www.bccresearch.com/report/IFT073A.html
Carbon Nanotubes: Technologies and Global Markets
The primary objective of this report is threefold:
- Assess the current state-of-the-art in Carbon Nanotubes (CNTs) production and technical applications understanding
- Identify the current players seeking to exploit their unique properties
- Evaluate actual or impending markets in terms of the technical readiness of CNTs and the projected market revenues.
Drug-device Combinations: The Global Market
This report discusses key markets for drug device combination products. It provides descriptions of technologies and products, a review of the status of R&D initiatives and a forecast of the market through 2014. Company profiles and a patent analysis are provided as well. Example product categories that are covered include drug-eluting stents (DES), drug-eluting beads (DEB), antimicrobial catheters, antibiotic-loaded bone cements, glass ionomer cements, bone graft substitutes, antibacterial releasing dental restorative materials, biologic wound care products such as collagen-based dressings as therapeutic agents for wound healing, drug device combination products for ocular applications, photodynamic therapy, and other important niches.
For more information on this report and to download the introduction chapter for free, visit http://www.bccresearch.com/report/PHM045B.html
Antennas for Systems and Devices: Technologies and Global Markets
This report tries to make sense of the exceptionally fragmented antenna market. Prima facie, it would not be wrong to assume that the antenna market should display a level of homogeneity found in the markets of other wireless communication components such as basebands, modems, and radio frequency (RF) front ends. Such an expectation is way off the mark. What dictates the dynamics of antenna markets is the end application. It is not uncommon to notice entire antenna supply chains built closely around the interest of end-application users, rather than being heavily focused on interactions with other value adders in the telecommunications domains.
For this reason, this report considers the end-application sector as the primary classification criterion. To render the maximum level of granularity to the study, the report has identified 10 end-application categories, which are further subdivided into antenna technologies, antenna materials, and geographical regions.
On the whole, BCC Research forecasts that the future of antennas will continue to be driven by that of its end applications. However, commonalities as mentioned above will lead to the adoption of smarter technologies in antenna synthesis and operations. The market is thus likely to witness antennas that are lighter, smaller, power efficient and, most importantly, intelligent.
For more information on this report and to download the introduction chapter for free, visit http://www.bccresearch.com/report/IFT073A.html
Friday, January 22, 2010
Access over 1000 Market Research Reports with BCC Research's Report Subscription Services
For companies and institutions that need regular access to market research, analysis and forecasts, the Reports Subscription Services from BCC is an ideal option. Each subscription package is customized to your organization's budget and business intelligence needs.
Visit http://www.bccresearch.com/subscribe_report.php for more information.
Call our Sales team at 866-285-7215 or e-mail reportsubs@bccresearch.com to discuss a Custom Report Subscription Package
Visit http://www.bccresearch.com/subscribe_report.php for more information.
Call our Sales team at 866-285-7215 or e-mail reportsubs@bccresearch.com to discuss a Custom Report Subscription Package
Tuesday, January 19, 2010
Global Market for Alzheimer’s Disease Therapeutics and Diagnostics to be worth $9.6 Billion In 2014
According to a new technical market research report, ALZHEIMER’S DISEASE THERAPEUTICS AND DIAGNOSTICS: GLOBAL MARKETS (PHM062A) from BCC Research (www.bccresearch.com), the value of the Alzheimer’s disease market is an estimated $8 billion in 2009, but is expected to increase to $9.6 billion in 2014, for a 5-year compound annual growth rate (CAGR) of 3.7%.
The largest segment of the market, disease-modifying therapeutics, is projected to decrease at a CAGR of -2.6%, dropping to $5.2 billion in 2014, after being valued at nearly $6 billion in 2009.
Diagnostics/biomarkers, the second-largest segment of the market, is estimated at $1.2 billion in 2009, and is expected to increase at a 5-year CAGR of 19.6% to reach nearly $2.9 billion in 2014.
The therapeutics for treatment of symptoms segment is expected to have a 5-year CAGR of 5.1%, with values of $567 million in 2009 and $726 million in 2014.
The smallest segment of the market, imaging products, is projected to have a healthy 5-year CAGR of 18.7%, rising from $361 million in 2009 to $852 million in 2014.
Alzheimer’s disease is becoming an increasingly difficult challenge to caregivers, families and the healthcare industry as the number of patients increases and the frustration with a lack of effective treatments grows. Though many marketed drugs have been approved for AD, this remains a significant area of unmet medical need. Clinical success has proven elusive; however, numerous companies are developing novel treatments.
BCC’s key objective was to present a comprehensive analysis of the current pipeline of therapeutic and diagnostic technologies, analyze the market, and outline key factors that will influence the therapeutic area in the next few years.
The intended audience for this report is the pharmaceutical and biotechnology industries and diagnostics, as well as the medical industry that treats patients in these areas.
The largest segment of the market, disease-modifying therapeutics, is projected to decrease at a CAGR of -2.6%, dropping to $5.2 billion in 2014, after being valued at nearly $6 billion in 2009.
Diagnostics/biomarkers, the second-largest segment of the market, is estimated at $1.2 billion in 2009, and is expected to increase at a 5-year CAGR of 19.6% to reach nearly $2.9 billion in 2014.
The therapeutics for treatment of symptoms segment is expected to have a 5-year CAGR of 5.1%, with values of $567 million in 2009 and $726 million in 2014.
The smallest segment of the market, imaging products, is projected to have a healthy 5-year CAGR of 18.7%, rising from $361 million in 2009 to $852 million in 2014.
Alzheimer’s disease is becoming an increasingly difficult challenge to caregivers, families and the healthcare industry as the number of patients increases and the frustration with a lack of effective treatments grows. Though many marketed drugs have been approved for AD, this remains a significant area of unmet medical need. Clinical success has proven elusive; however, numerous companies are developing novel treatments.
BCC’s key objective was to present a comprehensive analysis of the current pipeline of therapeutic and diagnostic technologies, analyze the market, and outline key factors that will influence the therapeutic area in the next few years.
The intended audience for this report is the pharmaceutical and biotechnology industries and diagnostics, as well as the medical industry that treats patients in these areas.
Subscribe to:
Posts (Atom)
Posts
